Holen Sie sich die Stockscreener-App
166.42
1.16%
-1.95
Handel nachbörslich:
166.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test - MedTech Dive
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Quest Diagnostics launches test for Oropouche virus amid spread in Americas - Investing.com Canada
Quest Diagnostics (DGX) Launches Oropouche Virus Test | DGX Stoc - GuruFocus
Quest Diagnostics Introduces Testing for Oropouche Virus - MarketScreener
First-Ever Commercial Test for Dangerous Oropouche Virus Launches as Disease Spreads in Americas - Stock Titan
Despite Slump, Options Traders May Be Seeing Something With Quest Diagnostics (DGX) - Barchart.com
Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center - Yahoo Finance
Quest Diagnostics Stock Drops 2.51% Amid Analyst Upgrade - AInvest
Quest Diagnostics (DGX) Launches FDA-Approved Alzheimer's Test - GuruFocus
Quest Diagnostics to offer Fujirebio Alzheimer's diagnostic test - Seeking Alpha
Quest Diagnostics Launches Revolutionary FDA-Cleared Blood Test to Detect Early Alzheimer's with 97% Accuracy - Stock Titan
Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating - MarketScreener
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It? - Yahoo Finance
Ex-Dividend Reminder: Edison International, Quest Diagnostics and Cousins Properties - Nasdaq
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant - TradingView
Quest Diagnostics tops NJ life sciences employer list - NJBIZ
Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now? - Yahoo Finance
What to Expect From Quest Diagnostics' Q2 2025 Earnings Report - inkl
What To Expect From Quest Diagnostics' Q2 2025 Earnings Report - Barchart.com
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance
DGX Stock Up on New Blood Test Development Deal With MD Anderson - MSN
Quest Diagnostics Transforms Healthcare Access: $13M in Grants, 1M Free Tests, and 50 New Diagnostic Services - Stock Titan
Is Quest Diagnostics Stock Outperforming The Nasdaq? - Barchart.com
Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga
Quest Diagnostics stock hits all-time high of $180.11 By Investing.com - Investing.com Canada
Quest partners with MD Anderson to develop cancer risk blood test - MedTech Dive
Quest Diagnostics and University of Texas want to promote more cancer screenings - Mugglehead Magazine
Fecal Immunochemical Diagnostic Test (FIT) Market Top - openPR.com
Quest Diagnostics (DGX) Collaborates with MD Anderson for Cancer Risk Test Development | DGX Stock News - GuruFocus
Quest Diagnostics New Blood Test Could Transform Early Cancer Detection for 9 Major Cancers - Stock Titan
Quest Diagnostics Incorporated : The stock forcefully approaches new pivot levels - MarketScreener
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology - Financial Times
Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth - DirectorsTalk Interviews
Transcript : Quest Diagnostics Incorporated Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - marketscreener.com
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance
Testing & Diagnostics Services Stocks Q1 Teardown: Quest (NYSE:DGX) Vs The Rest - Yahoo Finance
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Mee - GuruFocus
Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Meeting | DGX Stock News - GuruFocus
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? - The Globe and Mail
Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? - inkl
Is Wall Street Bullish Or Bearish On Quest Diagnostics Stock? - Barchart.com
Quest Diagnostics' $4M Rest Break Settlement Gets Initial OK - Law360
Quest Diagnostics (DGX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus
Quest Diagnostics Inc (DGX) Shares Gap Down to $171.44 on May 21 - GuruFocus
What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? - Yahoo Finance
Quest Diagnostics stock hits all-time high of $179.37 By Investing.com - Investing.com Nigeria
Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4) - Quantisnow
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PR Newswire
Lung Cancer Diagnostics Market Outlook: Opportunities in Early - openPR.com
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference – Company Announcement - Financial Times
Insider Sell: Mark Delaney Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus
Quest Diagnostics (DGX) Declares Consistent Dividend - GuruFocus
Quest Diagnostics Keeps Dividend at $0.80 per Share, Payable July 21 to Shareholders as of July 7 - marketscreener.com
Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):